Skip to main content

Advertisement

SpringerLink
Log in

The Secondary Prevention of Cardiometabolic Disease in Diabetes Patients: Novel Advancements and the Way Forward

  • Physical Activity (D Warburton, Section Editor)
  • Published:
Current Cardiovascular Risk Reports Aims and scope Submit manuscript

Abstract

The prevalence of type 2 diabetes mellitus (T2DM) in developed countries around the world has never before reached greater proportions. Given the chronic nature of the disease and its frequent, concomitant presence of cardiometabolic risk factors, patients with T2DM are most likely to experience fatalities associated with cardiovascular disease (CVD). Chronic cardiometabolic disease and T2DM are preventable, reversible, and can be delayed with the appropriate lifestyle choices or modifications. Recent findings examining intensive lifestyle interventions targeting weight loss, and the potential feasibility of incorporating high intensity interval training (HIIT) into the exercise regimens of patients with T2DM, encourage optimism as we, as a society, move into the future and seek a novel approach to extricate ourselves from this trend of premature death associated with chronic cardiometabolic disease. The way forward in the secondary prevention of cardiometabolic disease involves eliciting change in our perception of physical activity at the earliest stage in life possible: childhood.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.

    Article  PubMed  Google Scholar 

  2. World Health Organization. Global strategy on diet, physical activity and health: diabetes. Geneva: World Health Organization; 2006.

    Google Scholar 

  3. Simpson SH, Corabian P, Jacobs P, Johnson JA. The cost of major comorbidity in people with diabetes mellitus. CMAJ. 2003;168:1661–7.

    PubMed Central  PubMed  Google Scholar 

  4. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population. 1971-1993. Diabetes Care. 1998;21:1138–45.

    Article  CAS  PubMed  Google Scholar 

  5. Wilson PW, D’Agostino RB, Parise H, Sullivan L, Meigs JB. Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005;112:3066–72.

    Article  CAS  PubMed  Google Scholar 

  6. Centers for Disease Control and Prevention. National diabetes fact sheet: general information and national estimates of diabetes in the United States, 2007. Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2008.

    Google Scholar 

  7. Hogan P, Dall T, Nikolov P, American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917–32.

    Article  PubMed  Google Scholar 

  8. Roberts CK, Barnard RJ. Effects of exercise and diet on chronic disease. J Appl Physiol. 2005;98(1):3–30.

  9. American College of Sport M. ACSM’s guidelines for exercise testing and prescription. Philadelphia: Lippincott Williams & Wilkins; 2010.

    Google Scholar 

  10. The Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369:145–54. This study showed that despite marked improvements in weight loss and in cardiometabolic disease risk factors in overweight and obese patients with T2DM, and the partial reversal of T2DM after year 1 of intensive lifestyle intervention, a futility analysis forced the early termination of the study upon 10 years of follow-up, as the lack of sustainability of the intervention failed to yield a reduction in the prevalence of cardiovascular events compared to the control group. The authors wish to emphasize the key issue of lack of sustainability as the primary obstacle that must be addressed in the way forward in conquering chronic cardiometabolic disease.

    Article  PubMed Central  Google Scholar 

  11. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393–403.

    Article  PubMed Central  Google Scholar 

  12. Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1343–50.

    Article  CAS  PubMed  Google Scholar 

  13. Romeo S, Maglio C, Burza MA, et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care. 2012;35:2613–6.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  14. Carlsson LM, Peltonen M, Ahlin S, et al. Bariatric surgery and prevention of type 2 diabetes in Swedish Obese Subjects. N Engl J Med. 2012;367:695–704. This study was the first long-term, prospective, controlled trial investigating the effects of bariatric surgery in obese individuals (the majority of whom had T2DM) on cardiovascular morbidity and mortality upon 10 to 20 years of follow up. The study findings revealed that upon 10 years of follow-up, body weight was maintained at 23 % lower than pre-bariatric surgery, and this was associated with long-term decreases in incidence of diabetes, stroke, myocardial infarction, cancer, and overall mortality.

    Article  CAS  PubMed  Google Scholar 

  15. Colberg SR, Sigal RJ, Fernhall B, Regensteiner JG, Blissmer BG, Rubin RR, et al. Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary. Diabetes Care. 2010;33:2692–6.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. Diabetologia. 1991;34:891–8.

    Article  CAS  PubMed  Google Scholar 

  17. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and diabetes study. Diabetes Care. 1997;20:537–44.

    Article  CAS  PubMed  Google Scholar 

  18. Terada T, Friesen A, Chahal BS, Bell GJ, McCargar LJ, Boule NG. Feasibility and preliminary efficacy of high intensity interval training in type 2 diabetes. Diabetes Res Clin Pract. 2013;99:120–9. This was the first, longer-term (12 weeks), randomized, trial in patients with T2DM demonstrating the preliminary feasibility and efficacy of HIIT, compared to CMIT in this specific clinical population.

    Article  PubMed  Google Scholar 

  19. Terada T, Friesen A, Chahal BS, Bell GJ, McCargar LJ, Boule NG. Exploring the variability in acute glycemic responses to exercise in type 2 diabetes. J Diabetes Res. 2013;2013:591574.

    Article  PubMed Central  PubMed  Google Scholar 

  20. Karstoft K, Winding K, Knudsen SH, Nielsen JS, Thomsen C, Pedersen BK, et al. The effects of free-living interval-walking training on glycemic control, body composition, and physical fitness in type 2 diabetic patients”. Diabetes Care. 2013;36:228–36. This study was a randomized, control trial that provided further evidence for the feasibility and high adherence rates to a HIIT walking regimen in patients with T2DM. Importantly, this study demonstrated the superior improvements in body composition, glycemic control, and CRF in the HIIT group compared to an energy expenditure-matched CMIT walking group, and control group.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Hawley JA, Gibala MJ. What’s new since Hippocrates? Preventing type 2 diabetes by physical exercise and diet. Diabetologia. 2012;55:535–9.

    Article  CAS  PubMed  Google Scholar 

  22. Burgomaster KA, Howarth KR, Phillips SM, et al. Similar metabolic adaptations during exercise after low volume sprint interval and traditional endurance training in humans. J Physiol. 2008;586:151–60.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  23. Hood MS, Little JP, Tarnopolsky MA, Myslik F, Gibala MJ. Low-volume interval training improves muscle oxidative capacity in sedentary adults. Med Sci Sports Exerc. 2011;43:1849–56.

    Article  CAS  PubMed  Google Scholar 

  24. Weston KS, Wisloff U, Coombes JS. High-intensity interval training in patients with lifestyle-induced cardiometabolic disease: a systematic review and met-analysis. Br J Sports Med. 2013;1–9. doi:10.1136/bjsports-2013-092576

  25. Hwang CL, Wu YT, Chou CH. Effect of aerobic interval training on exercise capacity and metabolic risk factors in people with cardiometabolic disorders. J Cardiopulm Rehabil Prev. 2011;31:378–85.

    Article  PubMed  Google Scholar 

  26. Gulati M, Pandey DK, Arnsdorf MF, et al. Exercise capacity and the risk of death in women: the St James Women Take Heart Project. Circulation. 2003;108:1554–9.

    Article  PubMed  Google Scholar 

  27. Kaminsky LA, Arena R, Beckie TM, et al. The importance of cardiorespiratory fitness in the United States: the need for a national registry: a policy statement from the American Heart Association. Circulation. 2013;127:652–62.

    Article  PubMed  Google Scholar 

  28. American College of Sports Medicine. ACSM’s guidelines for graded exercise testing and prescription. 8th ed. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins; 2010.

    Google Scholar 

  29. Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, et al. The metabolic syndrome in children and adolescents-an IDF consensus report. Pediatr Diabetes. 2007;8:299–306.

    Article  PubMed  Google Scholar 

  30. Chen W, Srinivasan SR, Elkasabany A, Berenson GS. Cardiovascular risk factors clustering features of insulin resistance syndrome (Syndrome X) in a biracial (Black-White) population of children, adolescents, and young adults: the Bogalusa Heart Study. Am J Epidemiol. 1999;150:667–74.

    Article  CAS  PubMed  Google Scholar 

  31. Camhi SM, Katzmarzyk PT. Tracking of cardiometabolic risk factor clustering from childhood to adulthood. Int J Pediatr Obes. 2010;5:122–9.

    Article  PubMed  Google Scholar 

  32. Twisk JW, Kemper HC, van Mechelen W. The relationship between physical fitness and physical activity during adolescence and cardiovascular disease risk factors at adult age. The Amsterdam growth and health longitudinal study. Int J Sports Med. 2002;23 Suppl 1:S8–S14.

    Article  PubMed  Google Scholar 

  33. Twisk JW, van Kemper HC, Mechelen W. Tracking of activity and fitness and the relationship with cardiovascular disease risk factors. Med Sci Sports Exerc. 2000;32(8):1455–61.

    Article  CAS  PubMed  Google Scholar 

  34. Bailey DP, Boddy LM, Savory LA, Denton SJ, Kerr CJ. Associations between cardiorespiratory fitness, physical activity and clustered cardiometabolic risk in children and adolescents: the HAPPY study. Eur J Pediatr. 2012;171:1317–23. This study demonstrated that children and adolescents who were classified as being “fit”, according to objectively measured CRF values, had lower clustered cardiometabolic risk scores compared to their “unfit” counterparts. This is particularly relevant in light of the recent childhood obesity epidemic and lower CRF levels being reported in this population, as evidence shows that childhood CRF tracks into adulthood, along with cardiometabolic risk profile.

    Article  PubMed  Google Scholar 

  35. Ruiz JR, Ortega FB, Rizzo NS, Villa I, Hurtig-Wennlof A, Oja L, et al. High cardiovascular fitness is associated with low metabolic risk score in children: the European Youth Heart Study. Pediatr Res. 2007;61:350–5.

    Article  PubMed  Google Scholar 

  36. Carson V, Rinaldi RL, Torrance B, Maximova K, Ball GDC, Majumdar SR, et al. Vigorous physical activity and longitudinal associations with cardiometabolic risk factors in youth. Int J Obes. 2014;38:16–21. Using a prospective, longitudinal design, this study showed that greater time spent performing VPA, as distinguished specifically from time spent performing MVPA, was predictive of a more favourable cardiometabolic risk profile upon a 2-year follow-up period in youths. These findings emphasize the need for further investigation into optimal doses of VPA that confer the greatest benefit in the primary prevention of cardiometabolic disease in this population, which can then inform the PA guidelines for adults living with and without cardiometabolic disease moving into the future.

    Article  CAS  Google Scholar 

  37. Tremblay MS, Warburton DE, Janssen I, Paterson DH, Latimer AE, Rhodes RE, et al. New Canadian physical activity guidelines. Appl Physiol Nutr Metab. 2011;361:7–58.

    Google Scholar 

  38. WHO. Global recommendations on physical activity for health. Geneva: WHO Press; 2010.

    Google Scholar 

  39. US Department of Health and Human Services. US Department of Agriculture: Dietary Guidelines for Americans. 2005 March, 2010.

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Leanna Lee and Paul Oh declare no conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by the author.

Author information

Authors and Affiliations

  1. University Health Network Cardiovascular Prevention and Rehabilitation Program, Toronto Rehabilitation Institute (UHN-TRI), 347 Rumsey Road, Toronto, ON, Canada, M4G 1R7

    Leanna Lee & Paul Oh

Authors
  1. Leanna Lee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Paul Oh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Leanna Lee.

Additional information

This article is part of the Topical Collection on Physical Activity

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lee, L., Oh, P. The Secondary Prevention of Cardiometabolic Disease in Diabetes Patients: Novel Advancements and the Way Forward. Curr Cardiovasc Risk Rep 8, 396 (2014). https://doi.org/10.1007/s12170-014-0396-3

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s12170-014-0396-3

Keywords

Search

Navigation